Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Viatris IncVTRS · Entity 3277 | See Remarks | June 25, 2026 | June 26, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Viatris Inc
Report date June 25, 2026 · Filed June 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 316,212 |
Reported balance
After 2026-06-25 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-25 · Sale · Disposed 50,076 · Balance 316,212 F1: These shares of common stock were sold pursuant to a written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, that was adopted by the reporting person on March 24, 2026. F2: Represents the weighted average price of the reporting person's disposition of 50,076 shares of common stock in transactions ranging from $15.979 to $16.31. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock sold at each separate price within the range set forth in this footnote. |
| Common StockSEC Table I · non-derivative | IndirectBy 401(k) Plan | 318 |
Reported balance
Holding disclosure · report date 2026-06-25 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 318 |
Filing footnotes · ownership attribution and instrument terms
F1: These shares of common stock were sold pursuant to a written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, that was adopted by the reporting person on March 24, 2026.
F2: Represents the weighted average price of the reporting person's disposition of 50,076 shares of common stock in transactions ranging from $15.979 to $16.31. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock sold at each separate price within the range set forth in this footnote.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Mylan II B.V.
Report date November 16, 2020 · Filed November 19, 2020
Section 16 reporting ended · disclosed 2020-11-19. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Performance Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | IndirectBy Spouse | 933 |
Reported balance
After 2020-11-16 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-11-16 · Grant · Acquired 933 · Balance 933 F25: Each PRSU represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2020, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. |
| Performance Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | IndirectBy Spouse | 0 |
Reported balance
After 2020-11-16 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-11-16 · Disposition to issuer · Disposed 933 · Balance 0 F16: Represents PRSUs of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms (other than no longer being subject to the performance-based vesting conditions) in connection with the Combination. F25: Each PRSU represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2020, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. |
Filing footnotes · ownership attribution and instrument terms
F16: Represents PRSUs of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms (other than no longer being subject to the performance-based vesting conditions) in connection with the Combination.
F25: Each PRSU represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2020, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2021 Filed Mar 4, 2021 23:35 UTC | Viatris Inc VTRS · Entity 3277 | Tax withholdingCommon Stock | 132 | $14.29 | $1,886.28 |
DisclosureSEC source: 0000899243-21-009933 · doc4.xml · nonDerivative · entry 12 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 1,201 F3 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the RSUs granted on March 1, 2019. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 23:35 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 385 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-009933 · doc4.xml · nonDerivative · entry 11 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 1,333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 23:35 UTC | Viatris Inc VTRS · Entity 3277 | Tax withholdingCommon Stock | 1,854 | $14.29 | $26,493.66 |
DisclosureSEC source: 0000899243-21-009933 · doc4.xml · nonDerivative · entry 10 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,268 F3 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the RSUs granted on March 1, 2019. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 23:35 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 4,129 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-009933 · doc4.xml · nonDerivative · entry 9 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,122 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 23:35 UTC | Viatris Inc VTRS · Entity 3277 | Tax withholdingCommon Stock | 171 | $14.29 | $2,443.59 |
DisclosureSEC source: 0000899243-21-009933 · doc4.xml · nonDerivative · entry 8 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 948 F2 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of the RSUs granted on March 2, 2018. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 23:35 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 501 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-009933 · doc4.xml · nonDerivative · entry 7 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 1,119 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 23:35 UTC | Viatris Inc VTRS · Entity 3277 | Tax withholdingCommon Stock | 4,335 | $14.29 | $61,947.15 |
DisclosureSEC source: 0000899243-21-009933 · doc4.xml · nonDerivative · entry 6 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,993 F2 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of the RSUs granted on March 2, 2018. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 23:35 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 9,900 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-009933 · doc4.xml · nonDerivative · entry 5 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,328 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 23:35 UTC | Viatris Inc VTRS · Entity 3277 | Tax withholdingCommon Stock | 57 | $14.29 | $814.53 |
DisclosureSEC source: 0000899243-21-009933 · doc4.xml · nonDerivative · entry 4 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 618 F1 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on March 2, 2018. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 23:35 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 167 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-009933 · doc4.xml · nonDerivative · entry 3 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 675 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 23:35 UTC | Viatris Inc VTRS · Entity 3277 | Tax withholdingCommon Stock | 972 | $14.29 | $13,889.88 |
DisclosureSEC source: 0000899243-21-009933 · doc4.xml · nonDerivative · entry 2 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,428 F1 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on March 2, 2018. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 23:35 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 1,980 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-009933 · doc4.xml · nonDerivative · entry 1 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:14 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerPerformance Restricted Stock Units · Derivative | 933 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000899243-20-031496 · doc4.xml · derivative · entry 2 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Underlying: Ordinary Shares · 933 shares Expires not disclosed F16 · security: Represents PRSUs of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms (other than no longer being subject to the performance-based vesting conditions) in connection with the Combination. F16 · price: Represents PRSUs of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms (other than no longer being subject to the performance-based vesting conditions) in connection with the Combination. F25 · derivative.exercise_date: Each PRSU represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2020, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. F25 · derivative.expiration_date: Each PRSU represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2020, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:14 UTC | Mylan II B.V. MYL · Entity 16217 | GrantPerformance Restricted Stock Units · Derivative | 933 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-031496 · doc4.xml · derivative · entry 1 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 933 Underlying: Ordinary Shares · 933 shares Expires not disclosed F25 · derivative.exercise_date: Each PRSU represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2020, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. F25 · derivative.expiration_date: Each PRSU represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2020, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:11 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerPerformance Restricted Stock Units · Derivative | 25,744 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000899243-20-031488 · doc4.xml · derivative · entry 33 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 25,744 shares Expires not disclosed F16 · security: Represents PRSUs of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms (other than no longer being subject to the performance-based vesting conditions) in connection with the Combination. F16 · price: Represents PRSUs of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms (other than no longer being subject to the performance-based vesting conditions) in connection with the Combination. F25 · derivative.exercise_date: Each PRSU represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2020, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. F25 · derivative.expiration_date: Each PRSU represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2020, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:11 UTC | Mylan II B.V. MYL · Entity 16217 | GrantPerformance Restricted Stock Units · Derivative | 25,744 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-031488 · doc4.xml · derivative · entry 32 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,744 Underlying: Ordinary Shares · 25,744 shares Expires not disclosed F25 · derivative.exercise_date: Each PRSU represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2020, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. F25 · derivative.expiration_date: Each PRSU represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2020, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:11 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerRestricted Stock Units · Derivative | 1,866 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000899243-20-031488 · doc4.xml · derivative · entry 31 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Underlying: Ordinary Shares · 1,866 shares Expires not disclosed F13 · security: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination. F13 · price: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination. F24 · derivative.exercise_date: Each RSU represents the right to receive one ordinary share of Mylan. The RSUs will vest in three equal annual installments beginning on March 2, 2021. F24 · derivative.expiration_date: Each RSU represents the right to receive one ordinary share of Mylan. The RSUs will vest in three equal annual installments beginning on March 2, 2021. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:11 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerRestricted Stock Units · Derivative | 20,595 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000899243-20-031488 · doc4.xml · derivative · entry 30 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 20,595 shares Expires not disclosed F13 · security: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination. F13 · price: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination. F24 · derivative.exercise_date: Each RSU represents the right to receive one ordinary share of Mylan. The RSUs will vest in three equal annual installments beginning on March 2, 2021. F24 · derivative.expiration_date: Each RSU represents the right to receive one ordinary share of Mylan. The RSUs will vest in three equal annual installments beginning on March 2, 2021. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:11 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerEmployee Stock Option - Right to Buy · Derivative | 669 | Not disclosed Strike: $17.48 | Not disclosed |
DisclosureSEC source: 0000899243-20-031488 · doc4.xml · derivative · entry 29 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Underlying: Ordinary Shares · 669 shares Expires 2030-03-02 F3 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F3 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F23 · derivative.exercise_date: These options will vest in three equal annual installments beginning on March 2, 2021. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:11 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerEmployee Stock Option - Right to Buy · Derivative | 11,071 | Not disclosed Strike: $17.48 | Not disclosed |
DisclosureSEC source: 0000899243-20-031488 · doc4.xml · derivative · entry 28 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 11,071 shares Expires 2030-03-02 F3 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F3 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F22 · derivative.exercise_date: 3,691 of these options will vest on March 2, 2021 and 3,690 will vest on each of March 2, 2022 and March 2, 2023. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:11 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerPerformance Restricted Stock Units · Derivative | 577 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000899243-20-031488 · doc4.xml · derivative · entry 27 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Underlying: Ordinary Shares · 577 shares Expires not disclosed F16 · security: Represents PRSUs of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms (other than no longer being subject to the performance-based vesting conditions) in connection with the Combination. F16 · price: Represents PRSUs of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms (other than no longer being subject to the performance-based vesting conditions) in connection with the Combination. F21 · derivative.exercise_date: Each PRSU represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 1, 2019, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. F21 · derivative.expiration_date: Each PRSU represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 1, 2019, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:11 UTC | Mylan II B.V. MYL · Entity 16217 | GrantPerformance Restricted Stock Units · Derivative | 577 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-031488 · doc4.xml · derivative · entry 26 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 577 Underlying: Ordinary Shares · 577 shares Expires not disclosed F21 · derivative.exercise_date: Each PRSU represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 1, 2019, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. F21 · derivative.expiration_date: Each PRSU represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 1, 2019, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:11 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerPerformance Restricted Stock Units · Derivative | 15,483 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000899243-20-031488 · doc4.xml · derivative · entry 25 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 15,483 shares Expires not disclosed F16 · security: Represents PRSUs of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms (other than no longer being subject to the performance-based vesting conditions) in connection with the Combination. F16 · price: Represents PRSUs of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms (other than no longer being subject to the performance-based vesting conditions) in connection with the Combination. F21 · derivative.exercise_date: Each PRSU represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 1, 2019, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. F21 · derivative.expiration_date: Each PRSU represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 1, 2019, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:11 UTC | Mylan II B.V. MYL · Entity 16217 | GrantPerformance Restricted Stock Units · Derivative | 15,483 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-031488 · doc4.xml · derivative · entry 24 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,483 Underlying: Ordinary Shares · 15,483 shares Expires not disclosed F21 · derivative.exercise_date: Each PRSU represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 1, 2019, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. F21 · derivative.expiration_date: Each PRSU represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 1, 2019, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:11 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerRestricted Stock Units · Derivative | 770 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000899243-20-031488 · doc4.xml · derivative · entry 23 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Underlying: Ordinary Shares · 770 shares Expires not disclosed F13 · security: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination. F13 · price: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination. F20 · derivative.exercise_date: Each RSU represents the right to receive one ordinary share of Mylan. 385 of the RSUs will vest on each of March 2, 2021 and March 2, 2022. F20 · derivative.expiration_date: Each RSU represents the right to receive one ordinary share of Mylan. 385 of the RSUs will vest on each of March 2, 2021 and March 2, 2022. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:11 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerRestricted Stock Units · Derivative | 8,258 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000899243-20-031488 · doc4.xml · derivative · entry 22 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 8,258 shares Expires not disclosed F13 · security: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination. F13 · price: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination. F19 · derivative.exercise_date: Each RSU represents the right to receive one ordinary share of Mylan. 4,129 of the RSUs will vest on each of March 2, 2021 and March 2, 2022. F19 · derivative.expiration_date: Each RSU represents the right to receive one ordinary share of Mylan. 4,129 of the RSUs will vest on each of March 2, 2021 and March 2, 2022. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:11 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerEmployee Stock Option - Right to Buy · Derivative | 460 | Not disclosed Strike: $27.45 | Not disclosed |
DisclosureSEC source: 0000899243-20-031488 · doc4.xml · derivative · entry 21 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Underlying: Ordinary Shares · 460 shares Expires 2029-03-01 F3 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F3 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F18 · derivative.exercise_date: 154 of these options vested on March 2, 2020 and 153 will vest on each of March 2, 2021 and March 2, 2022. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:11 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerEmployee Stock Option - Right to Buy · Derivative | 7,398 | Not disclosed Strike: $27.45 | Not disclosed |
DisclosureSEC source: 0000899243-20-031488 · doc4.xml · derivative · entry 20 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 7,398 shares Expires 2029-03-01 F3 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F3 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F17 · derivative.exercise_date: One-third of these options vested on March 2, 2020 and one-third will vest on each of March 2, 2021 and March 2, 2022. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:11 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerPerformance Restricted Stock Units · Derivative | 501 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000899243-20-031488 · doc4.xml · derivative · entry 19 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Underlying: Ordinary Shares · 501 shares Expires not disclosed F16 · security: Represents PRSUs of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms (other than no longer being subject to the performance-based vesting conditions) in connection with the Combination. F16 · price: Represents PRSUs of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms (other than no longer being subject to the performance-based vesting conditions) in connection with the Combination. F15 · derivative.exercise_date: Each performance restricted stock unit ("PRSU") represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2018, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. F15 · derivative.expiration_date: Each performance restricted stock unit ("PRSU") represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2018, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:11 UTC | Mylan II B.V. MYL · Entity 16217 | GrantPerformance Restricted Stock Units · Derivative | 501 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-031488 · doc4.xml · derivative · entry 18 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 501 Underlying: Ordinary Shares · 501 shares Expires not disclosed F15 · derivative.exercise_date: Each performance restricted stock unit ("PRSU") represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2018, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. F15 · derivative.expiration_date: Each performance restricted stock unit ("PRSU") represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2018, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:11 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerPerformance Restricted Stock Units · Derivative | 9,900 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000899243-20-031488 · doc4.xml · derivative · entry 17 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 9,900 shares Expires not disclosed F16 · security: Represents PRSUs of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms (other than no longer being subject to the performance-based vesting conditions) in connection with the Combination. F16 · price: Represents PRSUs of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms (other than no longer being subject to the performance-based vesting conditions) in connection with the Combination. F15 · derivative.exercise_date: Each performance restricted stock unit ("PRSU") represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2018, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. F15 · derivative.expiration_date: Each performance restricted stock unit ("PRSU") represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2018, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:11 UTC | Mylan II B.V. MYL · Entity 16217 | GrantPerformance Restricted Stock Units · Derivative | 9,900 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-031488 · doc4.xml · derivative · entry 16 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,900 Underlying: Ordinary Shares · 9,900 shares Expires not disclosed F15 · derivative.exercise_date: Each performance restricted stock unit ("PRSU") represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2018, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. F15 · derivative.expiration_date: Each performance restricted stock unit ("PRSU") represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2018, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:11 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerRestricted Stock Units · Derivative | 167 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000899243-20-031488 · doc4.xml · derivative · entry 15 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Underlying: Ordinary Shares · 167 shares Expires not disclosed F13 · security: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination. F13 · price: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination. F14 · derivative.exercise_date: Each RSU represents the right to receive one ordinary share of Mylan. The RSUs will vest on March 2, 2021. F14 · derivative.expiration_date: Each RSU represents the right to receive one ordinary share of Mylan. The RSUs will vest on March 2, 2021. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:11 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerRestricted Stock Units · Derivative | 1,980 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000899243-20-031488 · doc4.xml · derivative · entry 14 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,980 shares Expires not disclosed F13 · security: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination. F13 · price: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination. F14 · derivative.exercise_date: Each RSU represents the right to receive one ordinary share of Mylan. The RSUs will vest on March 2, 2021. F14 · derivative.expiration_date: Each RSU represents the right to receive one ordinary share of Mylan. The RSUs will vest on March 2, 2021. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:11 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerEmployee Stock Option - Right to Buy · Derivative | 612 | Not disclosed Strike: $40.97 | Not disclosed |
DisclosureSEC source: 0000899243-20-031488 · doc4.xml · derivative · entry 13 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Underlying: Ordinary Shares · 612 shares Expires 2028-03-02 F3 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F3 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F12 · derivative.exercise_date: One-third of these options vested on each of March 2, 2019 and March 2, 2020 and one-third will vest on March 2, 2021. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:11 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerEmployee Stock Option - Right to Buy · Derivative | 9,681 | Not disclosed Strike: $40.97 | Not disclosed |
DisclosureSEC source: 0000899243-20-031488 · doc4.xml · derivative · entry 12 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 9,681 shares Expires 2028-03-02 F3 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F3 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F12 · derivative.exercise_date: One-third of these options vested on each of March 2, 2019 and March 2, 2020 and one-third will vest on March 2, 2021. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:11 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerEmployee Stock Option - Right to Buy · Derivative | 4,392 | Not disclosed Strike: $45.18 | Not disclosed |
DisclosureSEC source: 0000899243-20-031488 · doc4.xml · derivative · entry 11 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 4,392 shares Expires 2027-03-03 F3 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F3 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F11 · derivative.exercise_date: These options vested on March 3, 2020. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:11 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerEmployee Stock Option - Right to Buy · Derivative | 4,181 | Not disclosed Strike: $46.27 | Not disclosed |
DisclosureSEC source: 0000899243-20-031488 · doc4.xml · derivative · entry 10 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 4,181 shares Expires 2026-02-17 F3 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F3 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F10 · derivative.exercise_date: These options vested on February 17, 2019. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:11 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerEmployee Stock Option - Right to Buy · Derivative | 2,059 | Not disclosed Strike: $55.61 | Not disclosed |
DisclosureSEC source: 0000899243-20-031488 · doc4.xml · derivative · entry 9 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,059 shares Expires 2025-03-04 F3 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F3 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F9 · derivative.exercise_date: These options vested on March 4, 2018. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:11 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerEmployee Stock Option - Right to Buy · Derivative | 2,103 | Not disclosed Strike: $55.84 | Not disclosed |
DisclosureSEC source: 0000899243-20-031488 · doc4.xml · derivative · entry 8 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,103 shares Expires 2024-03-05 F3 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F3 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F8 · derivative.exercise_date: These options vested on March 5, 2017. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:11 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerEmployee Stock Option - Right to Buy · Derivative | 4,164 | Not disclosed Strike: $30.90 | Not disclosed |
DisclosureSEC source: 0000899243-20-031488 · doc4.xml · derivative · entry 7 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 4,164 shares Expires 2023-03-06 F3 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F3 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F7 · derivative.exercise_date: These options vested on March 6, 2016. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:11 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerEmployee Stock Option - Right to Buy · Derivative | 11,057 | Not disclosed Strike: $23.44 | Not disclosed |
DisclosureSEC source: 0000899243-20-031488 · doc4.xml · derivative · entry 6 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 11,057 shares Expires 2022-02-22 F3 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F3 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F6 · derivative.exercise_date: These options vested on February 22, 2015. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:11 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerEmployee Stock Option - Right to Buy · Derivative | 1,337 | Not disclosed Strike: $22.66 | Not disclosed |
DisclosureSEC source: 0000899243-20-031488 · doc4.xml · derivative · entry 5 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Underlying: Ordinary Shares · 1,337 shares Expires 2021-03-02 F3 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F3 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F5 · derivative.exercise_date: These options vested on February 27, 2015. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:11 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerEmployee Stock Option - Right to Buy · Derivative | 9,791 | Not disclosed Strike: $22.66 | Not disclosed |
DisclosureSEC source: 0000899243-20-031488 · doc4.xml · derivative · entry 4 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 9,791 shares Expires 2021-03-02 F3 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F3 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F4 · derivative.exercise_date: These options vested on March 2, 2014. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:11 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerOrdinary Shares | 508 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-031488 · doc4.xml · nonDerivative · entry 3 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 F1 · security: On November 16, 2020, Mylan N.V. ("Mylan") completed the transaction pursuant to which Mylan combined with Pfizer Inc.'s ("Pfizer") Upjohn business (the "Upjohn Business") in a Reverse Morris Trust transaction (the "Combination") and Upjohn Inc. ("Upjohn") became the parent entity of the combined Upjohn Business and Mylan business and was renamed "Viatris Inc." ("Viatris"). Pursuant to the terms of the Business Combination Agreement (as amended), dated July 29, 2019, by and among Mylan, Pfizer, Upjohn and certain other affiliated entities, Upjohn and Mylan effected the Combination through a series of transactions, including that (1) Mylan merged with and into Mylan II B.V. with Mylan II B.V. surviving the merger as the legal successor of Mylan and (2) each holder of Mylan ordinary shares received one share of Viatris common stock for each Mylan ordinary share held by such holder (subject to any required withholding tax). F2 · price: Represents ordinary shares of Mylan that were exchanged on a one-for-one basis for shares of Viatris common stock in connection with the Combination. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:11 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerOrdinary Shares | 318 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-031488 · doc4.xml · nonDerivative · entry 2 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By 401(k) Plan Disclosed balance after: 0 F1 · security: On November 16, 2020, Mylan N.V. ("Mylan") completed the transaction pursuant to which Mylan combined with Pfizer Inc.'s ("Pfizer") Upjohn business (the "Upjohn Business") in a Reverse Morris Trust transaction (the "Combination") and Upjohn Inc. ("Upjohn") became the parent entity of the combined Upjohn Business and Mylan business and was renamed "Viatris Inc." ("Viatris"). Pursuant to the terms of the Business Combination Agreement (as amended), dated July 29, 2019, by and among Mylan, Pfizer, Upjohn and certain other affiliated entities, Upjohn and Mylan effected the Combination through a series of transactions, including that (1) Mylan merged with and into Mylan II B.V. with Mylan II B.V. surviving the merger as the legal successor of Mylan and (2) each holder of Mylan ordinary shares received one share of Viatris common stock for each Mylan ordinary share held by such holder (subject to any required withholding tax). F2 · price: Represents ordinary shares of Mylan that were exchanged on a one-for-one basis for shares of Viatris common stock in connection with the Combination. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:11 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerOrdinary Shares | 30,336 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-031488 · doc4.xml · nonDerivative · entry 1 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: On November 16, 2020, Mylan N.V. ("Mylan") completed the transaction pursuant to which Mylan combined with Pfizer Inc.'s ("Pfizer") Upjohn business (the "Upjohn Business") in a Reverse Morris Trust transaction (the "Combination") and Upjohn Inc. ("Upjohn") became the parent entity of the combined Upjohn Business and Mylan business and was renamed "Viatris Inc." ("Viatris"). Pursuant to the terms of the Business Combination Agreement (as amended), dated July 29, 2019, by and among Mylan, Pfizer, Upjohn and certain other affiliated entities, Upjohn and Mylan effected the Combination through a series of transactions, including that (1) Mylan merged with and into Mylan II B.V. with Mylan II B.V. surviving the merger as the legal successor of Mylan and (2) each holder of Mylan ordinary shares received one share of Viatris common stock for each Mylan ordinary share held by such holder (subject to any required withholding tax). F2 · price: Represents ordinary shares of Mylan that were exchanged on a one-for-one basis for shares of Viatris common stock in connection with the Combination. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:48 UTC | Viatris Inc VTRS · Entity 3277 | GrantRestricted Stock Units · Derivative | 933 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000899243-20-031566 · doc4.xml · derivative · entry 29 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 933 Underlying: Common Stock · 933 shares Expires not disclosed F15 · security: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs will vest on March 2, 2021. F16 · price: Received in exchange for, and having substantially the same terms as (other than no longer being subject to the performance-based vesting conditions), performance restricted stock units of Mylan in connection with the Combination. F25 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs will vest on March 2, 2023. F25 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs will vest on March 2, 2023. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:48 UTC | Viatris Inc VTRS · Entity 3277 | GrantRestricted Stock Units · Derivative | 25,744 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000899243-20-031566 · doc4.xml · derivative · entry 28 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,744 Underlying: Common Stock · 25,744 shares Expires not disclosed F15 · security: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs will vest on March 2, 2021. F16 · price: Received in exchange for, and having substantially the same terms as (other than no longer being subject to the performance-based vesting conditions), performance restricted stock units of Mylan in connection with the Combination. F25 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs will vest on March 2, 2023. F25 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs will vest on March 2, 2023. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:48 UTC | Viatris Inc VTRS · Entity 3277 | GrantRestricted Stock Units · Derivative | 1,866 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000899243-20-031566 · doc4.xml · derivative · entry 27 Campbell Paul · CIK 0001657568 · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 1,866 Underlying: Common Stock · 1,866 shares Expires not disclosed F13 · security: One-third of these options vested on each of March 2, 2019 and March 2, 2020 and one-third will vest on March 2, 2021. F14 · price: Received in exchange for, and having substantially the same terms as, restricted stock units ("RSUs") of Mylan in connection with the Combination. F24 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs will vest in three equal annual installments beginning on March 2, 2021. F24 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs will vest in three equal annual installments beginning on March 2, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.